Project #21:
Direct Oral Anticoagulant (DOAC) prescribing during COVID-19.

During COVID-19, GPs have been encouraged to switch patients from Warfarin to alternative anticoagulants called Direct Oral Anticoagulants (DOACs) as they require less frequent monitoring and avoid additional visits to the GP practice. DOACs do however require renal function tests to ensure the correct dose is prescribed to avoid harm in patients. This evaluation wants to identify the proportion of patients who are at risk of harm whilst prescribed the incorrect dose of DOAC.